United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Sandoz to acquire biosimilar CIMERLI from Coherus BioSciences to expand ophthalmology portfolio In a significant development within the pharmaceutical and healthcare industry, Sandoz, a global leader in generic and biosimilar… byPallavi MadhirajuJanuary 24, 2024